Innoviva, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US45781M1018
USD
22.80
0.28 (1.24%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
101.45
118.05
111.26
103.74
92.09
95.24
92.96
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
101.45
118.05
111.26
103.74
92.09
95.24
92.96
Raw Material Cost
25.62
42.43
35.75
20.62
18.80
17.16
19.98
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
5.44
3.31
4.01
4.66
4.71
4.75
5.81
Selling and Distribution Expenses
32.44
32.07
27.26
26.38
27.46
31.27
26.20
Other Expenses
-0.02
0.12
0.97
0.33
-0.03
-0.11
-0.23
Total Expenditure (Excl Depreciation)
63.30
79.06
76.68
54.99
50.66
52.10
49.73
Operating Profit (PBDIT) excl Other Income
38.199999999999996
39
34.6
48.8
41.4
43.099999999999994
43.2
Other Income
10.62
5.54
4.99
4.15
3.54
5.89
4.59
Operating Profit (PBDIT)
58.82
54.65
49.68
62.93
54.93
59.03
57.81
Interest
5.44
3.31
4.01
4.66
4.71
4.75
5.81
Exceptional Items
191.22
153.82
62.26
24.36
-78.85
-19.59
-35.17
Gross Profit (PBDT)
75.83
75.61
75.51
83.11
73.28
78.08
72.98
Depreciation
10.04
10.12
10.11
10.04
9.96
10.00
9.99
Profit Before Tax
234.56
195.04
97.82
72.60
-38.59
24.69
6.85
Tax
47.97
30.88
7.91
8.91
8.00
4.36
5.64
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
186.59
164.15
89.91
63.69
-46.58
20.33
1.21
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
186.59
164.15
89.91
63.69
-46.58
20.33
1.21
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
186.59
164.15
89.91
63.69
-46.58
20.33
1.21
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
1,341.65
1,172.84
1,009.95
714.82
646.90
691.16
668.54
Earnings per share (EPS)
2.22
1.94
1.08
0.77
-0.74
0.28
0.02
Diluted Earnings per share
2.22
1.94
1.08
0.77
-0.74
0.28
0.02
Operating Profit Margin (Excl OI)
37.61%
33.03%
31.08%
46.99%
44.99%
45.3%
46.51%
Gross Profit Margin
241.11%
173.8%
97.0%
79.65%
-31.09%
36.42%
18.11%
PAT Margin
183.93%
139.06%
80.81%
61.39%
-50.59%
21.35%
1.3%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 10.10% vs 13.70% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 500.43% vs -227.67% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is -6.23% vs 43.58% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is 14.89% vs -20.34% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025

Compare Quarterly Results Of Innoviva, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
101.45
94.47
6.98
7.39%
Other Operating Income
0.00
0.00
0.00
Total Operating income
101.45
94.47
6.98
7.39%
Raw Material Cost
25.62
5.73
19.89
347.12%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
5.44
6.92
-1.48
-21.39%
Selling and Distribution Expenses
32.44
102.27
-69.83
-68.28%
Other Expenses
-0.02
1.24
-1.26
-101.61%
Total Expenditure (Excl Depreciation)
63.30
127.27
-63.97
-50.26%
Operating Profit (PBDIT) excl Other Income
38.15
-32.79
70.94
216.35%
Other Income
10.62
2.11
8.51
403.32%
Operating Profit (PBDIT)
58.82
-29.77
88.59
297.58%
Interest
5.44
6.92
-1.48
-21.39%
Exceptional Items
191.22
0.00
191.22
Gross Profit (PBDT)
75.83
88.75
-12.92
-14.56%
Depreciation
10.04
0.92
9.12
991.30%
Profit Before Tax
234.56
-37.60
272.16
723.83%
Tax
47.97
0.01
47.96
479,600.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
186.59
-37.60
224.19
596.25%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
186.59
-37.60
224.19
596.25%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
186.59
-37.60
224.19
596.25%
Equity Capital
0
0
0.00
Face Value
0.01
0.00
0.00
Reserves
1,341.65
148.62
1,193.03
802.74%
Earnings per share (EPS)
2.22
-0.15
2.37
1,580.00%
Diluted Earnings per share
2.22
-0.15
2.37
1,580.00%
Operating Profit Margin (Excl OI)
37.61%
-34.71%
0.00
72.32%
Gross Profit Margin
241.11%
-38.83%
0.00
279.94%
PAT Margin
183.93%
-39.81%
0.00
223.74%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 10.14 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -14.07% vs 6.02% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 10.10% vs 13.70% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 18.66 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 13.64% vs 82.65% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 500.43% vs -227.67% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.82 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -1.83% vs 9.84% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -6.23% vs 43.58% in Mar 2025

Quarterly - Interest
Interest 0.54 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 63.64% vs -17.50% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 14.89% vs -20.34% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 37.61%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025